Skip to main content
. 2022 Apr 11;12:21. doi: 10.1186/s13550-022-00893-z

Table 5.

[68Ga]NODAGA-RGDyK: M3 and M4 reassessed using αnew = 0.17

Target Organ Organ ADs (mGy/MBq) GA subject
M3 M4
Adrenals 1.30E−02 9.70E−03
Brain 4.96E−03 6.10E−03
Breasts 5.56E−03 6.62E−03
Oesophagus 6.43E−03 7.02E−03
Eyes 4.96E−03 6.10E−03
Gallbladder Wall 9.73E−03 8.52E−03
Left colon 2.55E−02 1.00E−02
Small Intestine 4.07E−02 1.43E−02
Stomach Wall 1.85E−02 8.92E−03
Right colon 2.60E−02 1.00E−02
Rectum 2.86E−02 1.36E−02
Heart Wall 9.02E−03 8.15E−03
Kidneys 5.10E−02 1.70E−02
Liver 3.14E−02 1.82E−02
Lungs 7.64E−03 1.17E−02
Ovaries 9.90E−03 1.05E−02
Pancreas 8.97E−03 8.05E−03
Prostate 9.52E−03 1.01E−02
Salivary Glands 5.24E−03 6.44E−03
Red Marrow 9.96E−03 9.34E−03
Osteogenic Cells 7.00E−03 6.96E−03
Spleen 2.19E−02 1.33E−02
Testes 5.60E−03 6.64E−03
Thymus 5.97E−03 7.19E−03
Thyroid 5.40E−03 6.60E−03
Urinary Bladder Wall 1.62E−01 1.63E−01
Uterus 1.37E−02 1.39E−02
Total Body 8.45E−03 8.45E−03
ED (mSv/MBq) 1.90E−02 1.52E−02